Longterm experience of magnerot administration in patients with mitral valve prolapse

Within 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic express...

Full description

Saved in:
Bibliographic Details
Main Authors: A. I. Martynov, E. V. Akatova
Format: Article
Language:Russian
Published: InterMedservice 2011-03-01
Series:Евразийский Кардиологический Журнал
Subjects:
Online Access:https://www.heartj.asia/jour/article/view/5423
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849692845981564928
author A. I. Martynov
E. V. Akatova
author_facet A. I. Martynov
E. V. Akatova
author_sort A. I. Martynov
collection DOAJ
description Within 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic expression of a dysplasia of a connecting tissue, changes of an electrocardiogram, a structure of the valves apparatus of heart, a condition of a vegetative homeostasis, change of level and a daily profile of arterial pressure, a tonus of sympathetic and parasympathetic departments of vegetative nervous system are taped. Against treatment according to the retrospective analysis significant improvement of clinic-tool indicators at all surveyed patients isn't. After regular application of magnesium salt orotate acids authentic improvement of quality of life at patients with prolepses the mitral valve is established.
format Article
id doaj-art-e30e7694797e4f17a86aacb6fcc8aef1
institution DOAJ
issn 2225-1685
2305-0748
language Russian
publishDate 2011-03-01
publisher InterMedservice
record_format Article
series Евразийский Кардиологический Журнал
spelling doaj-art-e30e7694797e4f17a86aacb6fcc8aef12025-08-20T03:20:36ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482011-03-0101132010.38109/2225-1685-2011-1-13-205420Longterm experience of magnerot administration in patients with mitral valve prolapseA. I. Martynov0E. V. Akatova1Московский государственный медико-стоматологический университетМосковский государственный медико-стоматологический университетWithin 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic expression of a dysplasia of a connecting tissue, changes of an electrocardiogram, a structure of the valves apparatus of heart, a condition of a vegetative homeostasis, change of level and a daily profile of arterial pressure, a tonus of sympathetic and parasympathetic departments of vegetative nervous system are taped. Against treatment according to the retrospective analysis significant improvement of clinic-tool indicators at all surveyed patients isn't. After regular application of magnesium salt orotate acids authentic improvement of quality of life at patients with prolepses the mitral valve is established.https://www.heartj.asia/jour/article/view/5423дисплазия соединительной тканипролапс митрального клапанакачество жизнивариабельность ритма сердцамагнеротa dysplasia of a connecting tissueprolaps the mitral valvequality of lifevariability of a rhythm of heartmagnerot
spellingShingle A. I. Martynov
E. V. Akatova
Longterm experience of magnerot administration in patients with mitral valve prolapse
Евразийский Кардиологический Журнал
дисплазия соединительной ткани
пролапс митрального клапана
качество жизни
вариабельность ритма сердца
магнерот
a dysplasia of a connecting tissue
prolaps the mitral valve
quality of life
variability of a rhythm of heart
magnerot
title Longterm experience of magnerot administration in patients with mitral valve prolapse
title_full Longterm experience of magnerot administration in patients with mitral valve prolapse
title_fullStr Longterm experience of magnerot administration in patients with mitral valve prolapse
title_full_unstemmed Longterm experience of magnerot administration in patients with mitral valve prolapse
title_short Longterm experience of magnerot administration in patients with mitral valve prolapse
title_sort longterm experience of magnerot administration in patients with mitral valve prolapse
topic дисплазия соединительной ткани
пролапс митрального клапана
качество жизни
вариабельность ритма сердца
магнерот
a dysplasia of a connecting tissue
prolaps the mitral valve
quality of life
variability of a rhythm of heart
magnerot
url https://www.heartj.asia/jour/article/view/5423
work_keys_str_mv AT aimartynov longtermexperienceofmagnerotadministrationinpatientswithmitralvalveprolapse
AT evakatova longtermexperienceofmagnerotadministrationinpatientswithmitralvalveprolapse